Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-02

Clinical Trial Update: The Effect of Balanced Crystalloid Versus 5% Albumin on Endothelial Glycocalyx Degradation in Patients Undergoing Off-pump Coronary Artery Bypass Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial comparing balanced crystalloids to 5% albumin on endothelial glycocalyx degradation in off-pump CABG patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5% albumin (albumin)
  • Balanced crystalloid solution (balanced crystalloid)

Snippet

Sponsor: Yonsei University | Conditions: Coronary Artery Occlusive Disease(CAOD) | Phase 4 | Status: COMPLETED